Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc. (IPCIQ) is a United States-based company traded on the OTC market. The company focuses on the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Intellipharmaceutics utilizes its proprietary drug delivery technologies to create pharmaceutical products with improved therapeutic profiles and patient compliance. The company's activities encompass the entire drug development process, from formulation and clinical trials to manufacturing and commercialization partnerships. Intellipharmaceutics aims to address unmet medical needs by developing innovative drug formulations that offer advantages over existing therapies, contributing to advancements in the pharmaceutical industry and improved patient outcomes.